Publications by authors named "Lorraine D Shelly"

Claim this Profile
C
Chronic treatment with epoxyeicosatrienoic acids modulates insulin signaling and prevents insulin resistance in hepatocytes.
Jill E Skepner, Lorraine D Shelly, Chengjie Ji, Benjamin Reidich, Yi Luo

Prostaglandins Other Lipid Mediat· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals.
Julie L Hawkins, Michael D Robbins, Laurie C Warren, Donghui Xia, Stephen F Petras, Lorraine D Shelly

J Pharmacol Exp Ther· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminopyrrolidineamide inhibitors of site-1 protease.
Bruce A Hay, Barbara Abrams, Allice Y Zumbrunn, James J Valentine, Laurie C Warren, Lorraine D Shelly

Bioorg Med Chem Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.
H James Harwood, Stephen F Petras, Lorraine D Shelly, Lawrence M Zaccaro, David A Perry

J Biol Chem· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis